Cargando…
The Extracellular Domain of Neurotrophin Receptor p75 as a Candidate Biomarker for Amyotrophic Lateral Sclerosis
Objective biomarkers for amyotrophic lateral sclerosis would facilitate the discovery of new treatments. The common neurotrophin receptor p75 is up regulated and the extracellular domain cleaved from injured neurons and peripheral glia in amyotrophic lateral sclerosis. We have tested the hypothesis...
Autores principales: | Shepheard, Stephanie R., Chataway, Tim, Schultz, David W., Rush, Robert A., Rogers, Mary-Louise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903651/ https://www.ncbi.nlm.nih.gov/pubmed/24475283 http://dx.doi.org/10.1371/journal.pone.0087398 |
Ejemplares similares
-
Urinary Extracellular Domain of Neurotrophin Receptor p75 as a Biomarker for Amyotrophic Lateral Sclerosis in a Chinese cohort
por: Jia, Rui, et al.
Publicado: (2017) -
Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations
por: Rogers, Mary-Louise, et al.
Publicado: (2023) -
Urinary p75(ECD): A prognostic, disease progression, and pharmacodynamic biomarker in ALS
por: Shepheard, Stephanie R., et al.
Publicado: (2017) -
Multifaceted Genes in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia
por: Ranganathan, Ramya, et al.
Publicado: (2020) -
Extracellular Vesicles in Amyotrophic Lateral Sclerosis
por: McCluskey, Gavin, et al.
Publicado: (2022)